| Profile | GDS4177 / 204812_at |
| Title | Imatinib treatment of chronic myeloid leukemia cell lines: KU-812, KCL-22 and JURL-MK1 |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM603100 | KU-812 Imatinib-treated | 485.95 | 90 |
| GSM603099 | KU-812 non-treated | 565.15 | 91 |
| GSM603098 | KCL-22 Imatinib-treated | 322.04 | 85 |
| GSM603097 | KCL-22 non-treated | 381.99 | 87 |
| GSM603102 | JURL-MK1 Imatinib-treated | 514.16 | 90 |
| GSM603101 | JURL-MK1 non-treated | 559.05 | 91 |